Atlas Trials

Safety and Feasibility of Nasal Delivery of Human Dental Follicle Mesenchymal Stem Cell-Derived Exosomes for Negative Symptoms in Treatment-Resistant Schizophrenia: A Pilot Study

Clinical trial NCT07485751 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07485751
Sponsor
Zigong Mental Health Center
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Schizophrenia Negative Type
Start date
2026-03-01
Primary completion
2026-09-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.